Table 2.
Impact on symptoms |
P | Impact on radiological findings |
P | |||
---|---|---|---|---|---|---|
Yes | No | Yes | No | |||
Bronchoscopy with/without any substance injected | 11 (50%) | 11 (50%) | 0.821 | 8 (36.4%) | 14 (63.6%) | 0.909 |
Bronchoscopy and rhDNase injection | 4 (44.4%) | 5 (55.6%) | 0.99 | 4 (44.4%) | 5 (55.6%) | 0.99 |
Bronchoscopy and saline injection | 6 (46.2%) | 7 (53.8%) | 0.869 | 5 (38.5%) | 8 (61.5%) | 0.848 |
rhDNase, recombinant human DNase.
Data are presented as n (%).
Comparisons between the groups were made using the chi-square test.